Malignant neoplasm of prostate (C61) ICD-10-CM
The C61 code range covers malignant neoplasm of prostate with 1 ICD-10-CM diagnosis codes. 1 of them are billable and valid for claim submission in fiscal year 2026, and the category headers group them but cannot themselves be billed.
Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code, if applicable, to identify:
- hormone sensitivity status Z19.1 Z19.2
- rising PSA following treatment for malignant neoplasm of prostate R97.21
Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- malignant neoplasm of seminal vesicle C63.7
Codes in the C61 Range 1 codes · 1 billable
- C61 Malignant neoplasm of prostate
About the C61 Code Range
The ICD-10 code C61 is used to identify malignant neoplasm of the prostate, or in simpler terms, prostate cancer. This code helps healthcare providers and coders classify tumors that originate in the prostate gland and its surrounding tissues.
C61 covers various forms of prostate cancer, including common and specific types like adenocarcinoma of the prostate, squamous cell carcinoma, and primary acinar cell cystadenocarcinoma. Synonyms such as "carcinoma of prostate," "primary malignant neoplasm of prostate," and "hormone refractory prostate cancer" are included to help clarify that all these terms fall under this single diagnostic code. Additionally, this code applies to prostate cancer that may extend into nearby organs like the seminal vesicles, urethra, or bladder. The ICD-10 code for malignant neoplasm of the prostate is essential for accurately documenting prostate cancer diagnoses, especially when dealing with localized, recurrent, or metastatic forms, including hormone-sensitive and castration-resistant variants.
Questions About This Page
How many billable codes are in the C61 range?
Of the 1 codes in this range, 1 are billable and valid for claim submission from October 1, 2025 through September 30, 2026. Category header codes group them but cannot be reported on claims.
What does the C61 range classify?
The range classifies malignant neoplasm of prostate. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.
Related References
Source: CMS FY 2026 ICD-10-CM Tabular List and order file, effective October 1, 2025 through September 30, 2026.
